The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Knocking down barriers: advances in siRNA delivery
Open accessAbstract
In the 10 years that have passed since the Nobel prize-winning discovery of RNA interference (RNAi), billions of dollars have been invested in the therapeutic application of gene silencing in humans. Today, there are promising data from ongoing clinical trials for the treatment of age-related macular degeneration and respiratory syncytial virus. Despite these early successes, however, the widespread use of RNAi therapeutics for disease prevention and treatment requires the development of clinically suitable, safe and effective drug delivery vehicles. Here, we provide an update on the progress of RNAi therapeutics and highlight novel synthetic materials for the encapsulation and intracellular delivery of nucleic acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, there has been an exponential growth in the development of clinically suitable nonviral delivery systems for siRNA (19,20); we have taken advantage of these innovations to develop the LNP/RNA formulation and have now embarked on a more extensive evaluation of other nonviral delivery systems.”
From Nonviral delivery of self-amplifying RNA vaccines (2012) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“There are limited published data on the in vivo delivery of self-amplifying RNA using nonviral delivery strategies (3,14,18), and none has taken advantage of the recently developed, clinically suitable delivery systems for siRNA (19,20).”
From Nonviral delivery of self-amplifying RNA vaccines (2012) · cites this paper as [20]
In the citing paper
“Additionally, endosomal membranes have been damaged or rebuilt using cell penetrating peptides to enhance the intracellular delivery of nucleic acids.313”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [313]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
Boussif, O., Lezoualc’h, F., Zanta, M. A., Djavaheri‐Mergny, M., Scherman, D., DEMENEIX, B. A., & Behr, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,256
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Role for a bidentate ribonuclease in the initiation step of RNA interference
Bernstein, E., Caudy, A. A., Hammond, S. M., & Hannon, G. J. (2001) · Nature · doi:10.1038/35053110 · Cited by 5,018
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., RINGOLD, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,954
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charissé, K., Constien, R., Donoghue, M., Elbashir, S. M., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,206
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Cited by
Sorted by citations
Items 301–400 of 1,004
In vivo delivery of RNAi with lipid-based nanoparticles
Huang, L., & Liu, Y. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124709 · Cited by 174
Cationic lipid nanoparticles for therapeutic delivery of siRNA and miRNA to murine liver tumor
Hsu, S., Yu, B., Wang, X., Lu, Y., Schmidt, C. R., Lee, R. J., Lee, L. J., Jacob, S. T., & Ghoshal, K. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.05.007 · Cited by 185
Devices for overcoming biological barriers: The use of physical forces to disrupt the barriers
Mitragotri, S. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.016 · Cited by 174
Current applications of graphene oxide in nanomedicine
An, S. S. A., Wu, S., & Hulme, J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s88285 · Cited by 173
Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue
Gote, V., Nookala, A. R., Bolla, P. K., & Pal, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094673 · Cited by 182
Multifunctionality of gold nanoparticles: Plausible and convincing properties
Ramalingam, V. (2019) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2019.101989 · Cited by 172
Local gene silencing in plants via synthetic ds RNA and carrier peptide
Numata, K., Ohtani, M., Yoshizumi, T., Demura, T., & Kodama, Y. (2014) · Plant Biotechnology Journal · doi:10.1111/pbi.12208 · Cited by 170
New insights into designing hybrid nanoparticles for lung cancer: Diagnosis and treatment
Mottaghitalab, F., Farokhi, M., Fatahi, Y., Atyabi, F., & Dinarvand, R. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.009 · Cited by 172
RNA-targeting and gene editing therapies for transthyretin amyloidosis
Aimo, A., Castiglione, V., Rapezzi, C., Franzini, M., Panichella, G., Vergaro, G., Gillmore, J. D., Fontana, M., Passino, C., & Emdin, M. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00683-z · Cited by 171
Pittella, F., Zhang, M., Lee, Y., Kim, H. J., Tockary, T. A., Osada, K., Ishii, T., Miyata, K., Nishiyama, N., & Kataoka, K. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.057 · Cited by 169
Curcumin in combination with anti-cancer drugs: A nanomedicine review
Batra, H., Pawar, S., & Bahl, D. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.005 · Cited by 170
Protein Cages: From Fundamentals to Advanced Applications
Edwardson, T. G. W., Levasseur, M. D., Tetter, S., Steinauer, A., Hori, M., & Hilvert, D. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00877 · Cited by 171
Biomimetic Delivery with Micro‐ and Nanoparticles
Balmert, S. C., & Little, S. R. (2012) · Advanced Materials · doi:10.1002/adma.201200224 · Cited by 168
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4
Ren, Y., Cheung, H. W., von Maltzhan, G., Agrawal, A., Cowley, G. S., Weir, B. A., Boehm, J. S., Tamayo, P., Karst, A. M., Liu, J. F., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003778 · Cited by 166
Kang, H., Ga, Y. J., Kim, S. H., Cho, Y. H., Kim, J., Kim, C., & Yeh, J. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00981-9 · Cited by 177
Peckys, D. B., & de Jonge, N. (2011) · Nano Letters · doi:10.1021/nl200285r · Cited by 170
Laroui, H., Viennois, É., Xiao, B., Canup, B. S. B., Geem, D., Denning, T. L., & Merlin, D. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.046 · Cited by 163
Branched and Dendritic Polymer Architectures: Functional Nanomaterials for Therapeutic Delivery
Cook, A. B., & Perrier, S. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201901001 · Cited by 164
Reshke, R., Taylor, J. A., Savard, A., Guo, H., Rhym, L. H., Kowalski, P. S., Trung, M. T., Campbell, C. M., Little, W., Anderson, D. G., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0502-4 · Cited by 165
Self-citationZhang, D., Atochina‐Vasserman, E. N., Maurya, D. S., Huang, N., Xiao, Q., Ona, N. A., Liu, M., Shahnawaz, H., Ni, H., Kim, K., et al. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05813 · Cited by 164
Multifunctional Nanogels for siRNA Delivery
Smith, M. H., & Lyon, L. A. (2011) · Accounts of Chemical Research · doi:10.1021/ar200216f · Cited by 163
Zhou, J., Neff, C. P., Liu, X., Zhang, J., Li, H., Smith, D. D., Swiderski, P. M., Aboellail, T., Huang, Y., Du, Q., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.207 · Cited by 161
Au, J. L. ‐., Yeung, B. Z., Wientjes, M. G., Lu, Z., & Wientjes, M. G. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.002 · Cited by 163
Cheng, Y., Sun, C., Liu, R., Yang, J., Dai, J., Zhai, T., Lou, X., & Xia, F. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901527 · Cited by 161
Nanoparticle-siRNA: A potential cancer therapy?
Young, S. W. S., Stenzel, M. H., & Jia-Lin, Y. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.10.015 · Cited by 161
Virus‐Mimicking Chimaeric Polymersomes Boost Targeted Cancer siRNA Therapy In Vivo
Zou, Y., Zheng, M., Yang, W., Meng, F., Miyata, K., Kim, H. J., Kataoka, K., & Zhong, Z. (2017) · Advanced Materials · doi:10.1002/adma.201703285 · Cited by 160
Self-Assembled Peptide Drug Delivery Systems
Yang, J., An, H., & Wang, H. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00707 · Cited by 164
BBB pathophysiology–independent delivery of siRNA in traumatic brain injury
Li, W., Qiu, J., Li, X.-L., Aday, S., Zhang, J., Conley, G., Xu, J., Joseph, J., Lan, H., Langer, R., et al. (2021) · Science Advances · doi:10.1126/sciadv.abd6889 · Cited by 160
Self-citationLee, S. J., Lee, A., Hwang, S. R., Park, J. S., Jang, J., Huh, M. S., Jo, D., Yoon, S.-Y., Byun, Y., Kim, S. H., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.245 · Cited by 159
Ultrasound-Targeted Microbubble Destruction to Deliver siRNA Cancer Therapy
Carson, A. R., McTiernan, C. F., Lavery, L., Grata, M., Leng, X., Wang, J., Chen, X., & Villanueva, F. S. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4079 · Cited by 159
Biomimetic Nanocarrier for Direct Cytosolic Drug Delivery
Zhang, Z., Cao, W., Jin, H., Lovell, J. F., Yang, M., Ding, L., Chen, J., Corbin, I. R., Luo, Q., & Zheng, G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903112 · Cited by 159
Single-Step Assembly of Cationic Lipid–Polymer Hybrid Nanoparticles for Systemic Delivery of siRNA
Yang, X., Dou, S., Wang, Y., Long, H., Xiong, M., Mao, C., Yao, Y., & Wang, J. (2012) · ACS Nano · doi:10.1021/nn300500u · Cited by 161
Lipid nanoparticles for short interfering RNA delivery
Leung, A. K. K., Tam, Y. Y. C., & Cullis, P. R. (2014) · Advances in genetics · doi:10.1016/b978-0-12-800148-6.00004-3 · Cited by 158
Lee, S. J., Huh, M. S., Lee, S. Y., Min, S., Lee, S., Koo, H., Chu, J., Lee, K. E., Jeon, H., Choi, Y., et al. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201201390 · Cited by 158
Delivery of molecules into cells using carbon nanoparticles activated by femtosecond laser pulses
Chakravarty, P., Qian, W. P., El‐Sayed, M. A., & Prausnitz, M. R. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.126 · Cited by 158
Xiao, Z., Levy‐Nissenbaum, E., Alexis, F., Lupták, A., Teply, B. A., Chan, J. M., Shi, J., Digga, E., Cheng, J. W. M., Langer, R., et al. (2012) · ACS Nano · doi:10.1021/nn204165v · Cited by 157
Self-citationClinical advances of siRNA therapeutics
Hu, B., Weng, Y., Xia, X., Liang, X., & Huang, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3097 · Cited by 162
Conformation-sensitive targeting of lipid nanoparticles for RNA therapeutics
Dammes, N., Goldsmith, M., Ramishetti, S., Dearling, J. L. J., Veiga, N., Packard, A. B., & Peer, D. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00928-x · Cited by 159
Huh, M. S., Lee, S. Y., Park, S.-J., Lee, S., Chung, H., Lee, S., Choi, Y., Oh, Y., Park, J. H., Jeong, S. Y., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.023 · Cited by 156
Acid-Degradable Cationic Dextran Particles for the Delivery of siRNA Therapeutics
Cohen, J. L., Schubert, S., Wich, P. R., Cui, L., Cohen, J. A., Mynar, J. L., & Fréchet, J. M. J. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100542r · Cited by 158
Recent Advances in Nanoparticle-Mediated siRNA Delivery
Williford, J., Wu, J., Ren, Y., Archang, M. M., Leong, K. W., & Mao, H. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071813-105119 · Cited by 161
Insight Into the Prospects for RNAi Therapy of Cancer
Tian, Z., Liang, G., Cui, K., Liang, Y., Wang, Q., Lv, S., Cheng, X., & Zhang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.644718 · Cited by 157
Shie, M., & Ding, S. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.075 · Cited by 154
Helmschrodt, C., Höbel, S., Schöniger, S., Bauer, A., Bonicelli, J., Gringmuth, M., Fietz, S. A., Aigner, A. M., Richter, A., & Richter, F. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.08.013 · Cited by 154
Progress and perspectives in developing polymeric vectors for in vitro gene delivery
Yue, Y., & Wu, C. C. (2012) · Biomaterials Science · doi:10.1039/c2bm00030j · Cited by 158
Capacity of mesoporous bioactive glass nanoparticles to deliver therapeutic molecules
El‐Fiqi, A., Kim, T.-H., Kim, M., Eltohamy, M. R., Won, J., Lee, E., & Kim, H. (2012) · Nanoscale · doi:10.1039/c2nr31775c · Cited by 152
Serrano-Sevilla, I., Artiga, Á., Mitchell, S. G., De Matteis, L., & de la Fuente, J. M. (2019) · Molecules · doi:10.3390/molecules24142570 · Cited by 148
Strategies for Targeting Gene Therapy in Cancer Cells With Tumor-Specific Promoters
Montaño-Samaniego, M., Bravo‐Estupiñan, D. M., Méndez-Guerrero, O., Alarcón-Hernández, E., & Ibáñez-Hernández, M. Á. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605380 · Cited by 159
Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**
Jayaraman, M., Ansell, S. M., Mui, B. L., Tam, Y. K., Chen, J., Du, X., Butler, D., Eltepu, L., Matsuda, S., Narayanannair, J. K., et al. (2012) · Angewandte Chemie · doi:10.1002/ange.201203263 · Cited by 150
The therapeutic potential of phosphatase inhibitors
Vintonyak, V. V., Antonchick, A. P., Rauh, D., & Waldmann, H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.021 · Cited by 150
Multifaceted Applications of Chitosan in Cancer Drug Delivery and Therapy
Babu, A., & Ramesh, R. (2017) · Marine Drugs · doi:10.3390/md15040096 · Cited by 154
Nanotechnology: emerging tools for biology and medicine
Wong, I. Y., Bhatia, S. N., & Toner, M. (2013) · Genes & Development · doi:10.1101/gad.226837.113 · Cited by 132
Xie, Y., Qiao, H., Su, Z., Chen, M., Ping, Q., & Sun, M. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.068 · Cited by 152
Engineering functional inorganic–organic hybrid systems: advances in siRNA therapeutics
Shen, J., Zhang, W., Qi, R., Mao, Z., & Shen, H. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00479f · Cited by 149
Emerging nanomaterials for targeting subcellular organelles
Huang, J. G., Leshuk, T. M. C., & Gu, F. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.002 · Cited by 149
Chemical and structural modifications of RNAi therapeutics
Ku, S. H., Jo, S. D., Lee, Y. K., Kim, K., & Kim, S. H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.015 · Cited by 146
Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
Prieve, M. G., Harvie, P., Monahan, S. D., Roy, D., Li, A. G., Blevins, T. L., Paschal, A. E., Waldheim, M., Bell, E. C., Galperin, A., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.024 · Cited by 145
Poking cells for efficient vector-free intracellular delivery
Wang, Y., Yang, Y., Yan, L., Kwok, S.-Y., Li, W., Wang, Z., Zhu, X. A., Zhu, G., Zhang, W., Chen, X., et al. (2014) · Nature Communications · doi:10.1038/ncomms5466 · Cited by 144
Gu, J., Al-Bayati, K., & Ho, E. A. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0368-5 · Cited by 145
Timko, B. P., Whitehead, K. A., Gao, W., Kohane, D. S., Farokhzad, O. C., Anderson, D. G., & Langer, R. (2011) · Annual Review of Materials Research · doi:10.1146/annurev-matsci-062910-100359 · Cited by 143
Self-citationControlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing
Wang, Y., Malcolm, D. W., & Benoit, D. S. W. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.06.001 · Cited by 143
Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping
Zheng, Z., Li, Z., Xu, C., Guo, B., & Guo, P. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.021 · Cited by 143
Advanced Materials for Co‐Delivery of Drugs and Genes in Cancer Therapy
Khan, M., Ong, Z. Y., Wiradharma, N., Attia, A. B. E., & Yang, Y. Y. (2012) · Advanced Healthcare Materials · doi:10.1002/adhm.201200109 · Cited by 142
Cell-penetrating peptides for the delivery of nucleic acids
Lehto, T., Kurrikoff, K., & Langel, Ü. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.689285 · Cited by 143
Tuning PEGylation of mixed micelles to overcome intracellular and systemic siRNA delivery barriers
Miteva, M., Kirkbride, K. C., Kilchrist, K. V., Werfel, T. A., Li, H., Nelson, C. E., Gupta, M. K., Giorgio, T. D., & Duvall, C. L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.10.036 · Cited by 140
Current Progress of RNA Aptamer-Based Therapeutics
Zhou, J., Bobbin, M. L., Burnett, J., & Rossi, J. J. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00234 · Cited by 140
Corona-Directed Nucleic Acid Delivery into Hepatic Stellate Cells for Liver Fibrosis Therapy
Zhang, Z., Wang, C., Zha, Y., Hu, W., Gao, Z., Zang, Y., Chen, J., Zhang, J., & Dong, L. (2015) · ACS Nano · doi:10.1021/nn505166x · Cited by 142
Alshaer, W., Hillaireau, H., Vergnaud, J., Mura, S., Deloménie, C., Sauvage, F., Ismail, S. I., & Fattal, E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.022 · Cited by 140
Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy
Mukalel, A. J., Riley, R., Zhang, R., & Mitchell, M. J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.040 · Cited by 143
Lipid Delivery Systems for Nucleic-Acid-Based-Drugs: From Production to Clinical Applications
Barba, A. A., Bochicchio, S., Dalmoro, A., & Lamberti, G. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11080360 · Cited by 147
Lee, S. M., Cheng, Q., Yu, X., Liu, S., Johnson, L. T., & Siegwart, D. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202013927 · Cited by 142
Multifunctional polymeric nanoparticles for oral delivery of TNF-α siRNA to macrophages
He, C., Yin, L., Tang, C., & Yin, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.01.033 · Cited by 139
PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer
Xiang, B., Dong, D., Shi, N., Gao, W., Yang, Z., Cui, Y., De-ying, C., & Qi, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.055 · Cited by 139
In Vivo Sustained Release of siRNA from Solid Lipid Nanoparticles
Lobovkina, T., Jacobson, G. B., González-González, E., Hickerson, R. P., Leake, D., Kaspar, R. L., Contag, C. H., & Zare, R. N. (2011) · ACS Nano · doi:10.1021/nn203745n · Cited by 139
siRNA applications in nanomedicine
Tokatlian, T., & Segura, T. (2010) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.81 · Cited by 138
Ornelas, C., Wich, P. R., & Fréchet, J. M. J. (2012) · Journal of the American Chemical Society · doi:10.1021/ja207366k · Cited by 138
Zhang, Y., Leonard, M., Shu, Y., Yang, Y., Shu, D., Guo, P., & Zhang, X. (2016) · ACS Nano · doi:10.1021/acsnano.6b05910 · Cited by 138
Saw, P. E., Yao, H., Lin, C., Tao, W., Farokhzad, O. C., & Xu, X. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b01660 · Cited by 138
Current Advances in Black Phosphorus‐Based Drug Delivery Systems for Cancer Therapy
Liu, W., Dong, A., Wang, B., & Zhang, H. (2021) · Advanced Science · doi:10.1002/advs.202003033 · Cited by 139
Li, F., Yu, W., Zhang, J., Dong, Y., Ding, X., Ruan, X., Gu, Z., & Yang, D. (2021) · Nature Communications · doi:10.1038/s41467-021-21442-7 · Cited by 139
Renaissance of aliphatic polycarbonates: New techniques and biomedical applications
Xu, J., Feng, E., & Song, J. (2013) · Journal of Applied Polymer Science · doi:10.1002/app.39822 · Cited by 147
Nanotechnology approaches in the current therapy of skin cancer
Borgheti-Cardoso, L. N., Viegas, J. S. R., Silvestrini, A. V. P., Caron, A. L., Praça, F. S. G., Kravicz, M., & Bentley, M. V. L. B. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.02.005 · Cited by 141
Li, L., Sun, W. Y., Zhong, J., Yang, Q., Zhu, X. D., Zhou, Z., Zhang, Z., & Huang, Y. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501248 · Cited by 135
Cho, H. Y., Srinivasan, A., Hong, J., Hsu, E., Liu, S., Shrivats, A. R., Kwak, D. H., Bohaty, A. K., Paik, H., Hollinger, J. O., et al. (2011) · Biomacromolecules · doi:10.1021/bm2006455 · Cited by 137
An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells
Wilner, S. E., Wengerter, B. C., Maier, K. E., Magalhães, M. D. L. B., del Amo, D. S., Pai, S., Opazo, F., Rizzoli, S. O., Yan, A. C., & Levy, M. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.14 · Cited by 138
Promise and Challenge of RNA Interference–Based Therapy for Cancer
Petrocca, F., & Lieberman, J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.6287 · Cited by 138
Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
Novobrantseva, T. I., Borodovsky, A., Wong, J., Klebanov, B., Zafari, M. R., Yucius, K., Querbes, W., Ge, P., Ruda, V. M., Milstein, S., et al. (2012) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2011.3 · Cited by 137
Self-citationKnipe, J. M., Strong, L. E., & Peppas, N. A. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01518 · Cited by 135
Virus‐Inspired Polymer for Efficient In Vitro and In Vivo Gene Delivery
Cheng, Y., Yumul, R., & Pun, S. H. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605958 · Cited by 135
Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer
Qu, M., Zeng, R., Fang, S., Dai, Q., Li, H., & Long, J. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.08.019 · Cited by 134
Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
Zhu, X., Tao, W., Liu, D. X., Wu, J., Guo, Z., Ji, X., Bharwani, Z., Zhao, L., Zhao, X., Farokhzad, O. C., et al. (2017) · Theranostics · doi:10.7150/thno.18136 · Cited by 138
RNA viruses and the host microRNA machinery
tenOever, B. R. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2971 · Cited by 134
Lipid-Based Nanoparticles in The Systemic Delivery of siRNA
Lin, Q., Chen, J., Zhang, Z., & Zheng, G. (2013) · Nanomedicine · doi:10.2217/nnm.13.192 · Cited by 133
Visualization of self-delivering hydrophobically modified siRNA cellular internalization
Ly, S., Navaroli, D. M., Didiot, M.-C., Cardia, J., Pandarinathan, L., Alterman, J. F., Fogarty, K., Standley, C., Lifshitz, L. M., Bellve, K. D., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1005 · Cited by 132
Cellular uptake and intracellular trafficking of oligonucleotides
Juliano, R. L., & Carver, K. A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.04.005 · Cited by 138
Jin, Y., Xu, G., YAO, Y., Li, Jin, Y., & Ying, J. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s32188 · Cited by 137
PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma
Wu, Y., Zhang, Y., Qin, X., Geng, H., Zuo, D., & Zhao, Q. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105195 · Cited by 132
Juliano, R. L., Ming, X., Carver, K. A., & Laing, B. M. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0463 · Cited by 135
Nanotechnology and the Treatment of HIV Infection
Parboosing, R., Maguire, G. E. M., Govender, P., & Kruger, H. G. (2012) · Viruses · doi:10.3390/v4040488 · Cited by 130
Ayoubi‐Joshaghani, M. H., Seidi, K., Azizi, M., Jaymand, M., Javaheri, T., Jahanban‐Esfahlan, R., & Hamblin, M. R. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004098 · Cited by 130
Metadata
- Authors
- Whitehead, K. A., Langer, R., & Anderson, D. G.
- Affiliations
- Massachusetts Institute of Technology (US)
- Koch Institute for Integrative Cancer Research At MIT (US)
- Corresponding author
- Anderson, Daniel G.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2009-02
- Volume
- 8
- Issue
- 2
- Pages
- 129-138
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC7097568
- OpenAlex
- W1964146045
- Cited by
- 3,115
- References
- 106
- Citations by year
- 2026: 96 · 2025: 114 · 2024: 150 · 2023: 120 · 2022: 159 · 2021: 207 · 2020: 148 · 2019: 191 · 2018: 183 · 2017: 199 · 2016: 220 · 2015: 218 · 2014: 240 · 2013: 233 · 2012: 222
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- siRNA delivery, RNA interference therapy, gene silencing, nucleic acid encapsulation, intracellular delivery, age-related macular degeneration, respiratory syncytial virus, clinical trials
- MeSH terms
- Animals, Clinical Trials as Topic, Humans, Liposomes, Drug Delivery Systems, RNA Interference, RNA, Small Interfering, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
